← Evidence map

ReviewOncogene2025

Combination strategies with PARP inhibitors in BRCA-mutated triple-negative breast cancer: overcoming resistance mechanisms.

Aditi Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39572842